Free Trial

Procter & Gamble (NYSE:PG) Shares Down 0.2% - Here's What Happened

Procter & Gamble logo with Consumer Staples background

The Procter & Gamble Company (NYSE:PG - Get Free Report) was down 0.2% on Tuesday . The company traded as low as $169.66 and last traded at $170.34. Approximately 988,316 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 6,651,482 shares. The stock had previously closed at $170.75.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Piper Sandler started coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a "neutral" rating and a $174.00 target price for the company. Wolfe Research raised Procter & Gamble to a "strong-buy" rating in a research report on Friday, August 23rd. Morgan Stanley upped their price target on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an "overweight" rating in a research report on Monday, October 21st. Royal Bank of Canada restated a "sector perform" rating and set a $164.00 target price on shares of Procter & Gamble in a research report on Monday, October 21st. Finally, Evercore ISI lifted their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an "outperform" rating in a research note on Monday, October 21st. Nine equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Procter & Gamble has an average rating of "Moderate Buy" and a consensus price target of $177.00.

Read Our Latest Research Report on Procter & Gamble

Procter & Gamble Stock Down 0.2 %

The company has a fifty day moving average of $170.21 and a two-hundred day moving average of $168.45. The company has a market cap of $401.32 billion, a PE ratio of 29.37, a price-to-earnings-growth ratio of 3.67 and a beta of 0.42. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Friday, October 18th. The company reported $1.93 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.03. The firm had revenue of $21.74 billion during the quarter, compared to analysts' expectations of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The company's revenue was down .6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.83 EPS. As a group, analysts anticipate that The Procter & Gamble Company will post 6.94 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.36%. The ex-dividend date was Friday, October 18th. Procter & Gamble's dividend payout ratio is presently 69.48%.

Insider Activity

In other news, CEO Jon R. Moeller sold 87,979 shares of the firm's stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.40, for a total value of $14,991,621.60. Following the transaction, the chief executive officer now owns 300,777 shares in the company, valued at $51,252,400.80. This trade represents a 22.63 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Ma. Fatima Francisco sold 96,000 shares of the firm's stock in a transaction that occurred on Thursday, August 22nd. The shares were sold at an average price of $170.00, for a total value of $16,320,000.00. Following the completion of the transaction, the chief executive officer now owns 13,721 shares in the company, valued at approximately $2,332,570. This trade represents a 87.49 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 270,727 shares of company stock valued at $46,014,037. Company insiders own 0.18% of the company's stock.

Hedge Funds Weigh In On Procter & Gamble

A number of institutional investors have recently added to or reduced their stakes in the stock. Itau Unibanco Holding S.A. purchased a new stake in shares of Procter & Gamble in the second quarter valued at about $28,000. Fairway Wealth LLC purchased a new stake in shares of Procter & Gamble in the 2nd quarter valued at approximately $29,000. RPg Family Wealth Advisory LLC purchased a new stake in shares of Procter & Gamble during the 3rd quarter valued at approximately $33,000. POM Investment Strategies LLC acquired a new position in Procter & Gamble in the second quarter valued at approximately $34,000. Finally, Quest Partners LLC purchased a new position in Procter & Gamble in the second quarter worth approximately $36,000. Hedge funds and other institutional investors own 65.77% of the company's stock.

About Procter & Gamble

(Get Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

'Best Report in 2 Years': NVIDIA Earnings Crushes Expectations Again

'Best Report in 2 Years': NVIDIA Earnings Crushes Expectations Again

With revenue growth nearing 95%, margins widening, and earnings soaring 111%, this might be NVIDIA's most impressive performance yet.

Related Videos

How to Profit from NVIDIA’s Earnings: Short-Term Trading Guide
NVIDIA Nears All-Time Highs: How High Can This AI Leader Climb?
What the Bulls and Bears Are Saying About NVIDIA Stock

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines